Get startedLog in
    Picture of Suzhou Ribo Life Science logo

    6938 — Suzhou Ribo Life Science News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapSucker Stock
    All News

    Brief: Suzhou Ribo Life Science Says RBD5044 Injection Approved For Phase Ii Clinical Trial In China

    Picture of Suzhou Ribo Life Science logoSuzhou Ribo Life Science
    23/01/2026 01:24
    Jan 23 (Reuters) - Suzhou Ribo Life Science Co Ltd 6938.HK:

RBD5044 INJECTION APPROVED FOR PHASE II CLINICAL TRIAL IN CHINA

Further company coverage: 6938.HK

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Suzhou Ribo Life Science

    See all news